Improvement in Disease-Free Survival with Doxorubicin/Docetaxel/Cyclophosphamide (TAC) Versus 5-Fluorouracil/Doxorubicin/Cyclophosphamide (FAC) as Adjuvant Therapy for Node-Positive Breast Cancer
Amy I. D'Orazio, Joyce O'ShaughnessyVolume:
3
Year:
2002
Language:
english
DOI:
10.1016/s1526-8209(11)70170-7
File:
PDF, 96 KB
english, 2002